查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
人白血球型抗原檢驗的全球市場預測(到2028年):COVID-19影響，產品·服務，技術，終端用戶，各地區的分析
市場調查報告書
商品編碼
1095012

人白血球型抗原檢驗的全球市場預測(到2028年):COVID-19影響，產品·服務，技術，終端用戶，各地區的分析

Human Leukocyte Antigen Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Services, Technology, and End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 221 Pages | 訂單完成後即時交付

價格

全球人白血球型抗原檢驗的市場規模在2021年估算為6億9,774萬美金，2021年～2028年間預測將以7.5％的年複合成長率擴大，到2028年前將達到11億5,565萬美元。

這份報告提供全球人白血球型抗原檢驗市場調查，提供市場概要，市場的推動因素與阻礙因素的分析，市場機會，COVID-19影響，各市場區隔的市場分析，競爭情形，主要企業的簡介等系統性資訊。

目錄

第1章 簡介

第2章 人白血球型抗原(HLA)檢驗市場:重要的要點

第3章 調查手法

第4章 人白血球型抗原(HLA)檢驗市場:市場形勢

  • 概要
  • PEST分析
  • 專家的見解

第5章 人白血球型抗原(HLA)檢驗市場:主要的市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 今後趨勢
  • 影響分析

第6章 全球人白血球型抗原(HLA)檢驗市場:全球市場分析

  • 世界市場收益預測與分析
  • 企業分析

第7章 全球人白血球型抗原(HLA)檢驗市場收益和2028年前的預測:產品·各類服務

  • 概要
  • 產品·各類服務的市場佔有率(2022年及2028年)
  • 試劑與消耗品
  • 設備
  • 軟體和服務

第8章 全球人白血球型抗原(HLA)檢驗市場收益和2028年前的預測:各技術

  • 概要
  • 各技術的市場(2022年及2028年)
  • 分子化驗技術
  • 非分子化驗技術

第9章 全球人白血球型抗原(HLA)檢驗市場收益和2028年前的預測:各終端用戶

  • 概要
  • 各終端用戶的市場(2022年及2028年)
  • 獨立索引·實驗室
  • 醫院及移植中心
  • 其他

第10章 全球人白血球型抗原(HLA)檢驗市場收益和2028年前的預測:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 中南美

第11章 COVID-19對地區的COVID-19疫情的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 中南美

第12章 人白血球型抗原(HLA)檢驗市場:產業形勢

  • 概要
  • 市場上成長策略
  • 有機的開發
  • 無機的開發

第13章 企業簡介

  • THERMO FISHER SCIENTIFIC INC.
  • CareDx
  • QIAGEN
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • TBG Diagnostics Limited
  • F. HOFFMANN-LA ROCHE LTD.
  • Takara Bio Inc.
  • Luminex Corporation
  • Omixon Inc.
  • The Sequencing Center
  • Protrans
  • HistoGenetics LLC
  • CD Genomics
  • Quintara Biosciences
  • CeGaT GmbH
  • CREATIVE BIOLABS, INC.

第14章 附錄

  • The Insight Partners
  • 詞彙表
Product Code: TIPRE00021578

The human leukocyte antigen (HLA) market is projected to reach US$ 1,155.65 million by 2028 from US$ 697.74 million in 2021; it is expected to register a CAGR of 7.5% from 2022 to 2028.

The increasing number of plasma donation and organ transplantation procedures and expanding range of applications of HLA testing are driving the market growth. However, errors in accuracy hamper the human leukocyte antigen (HLA) market growth.

Human leukocyte antigens (HLAs) are the specialized proteins present on all cell surfaces of the human body, except red blood cells. HLA testing has significant application in organ transplantation, which can be recommended as a part of the treatment of kidney failure, chronic liver cirrhosis, and chronic heart disease, among other medical issues. The growing prevalence of chronic diseases and organ failure leads to high demand for organ transplant procedures, as well as HLA testing. Before transplantation, HLA testing is performed to check tissue compatibility between patients and donors to avoid graft rejection. In recent years, transplantation has become a successful practice worldwide. According to data published in Global Observatory on Donation and Transplantation (GODT), in 2020, 129,681 organ transplants were recorded in total. Of these, 31.7% were living kidney transplants and 20.40% were living liver transplants.

Governments of various countries are taking initiatives to spread awareness about the need for organ donation and the benefits of organ transplantation in certain treatment procedures. For Instance, the Organ Procurement and Transplantation Network (OPTN) has implemented a few strategies to improve the number of organ transplantation procedures in the US. These strategies focus on increasing the number of organ and tissue transplants among patients with end-stage organ disease, altering the current organ distribution, and modifying the organ transplantation waitlist by redistributing the existing organ soppy. Furthermore, the OPTN has used out-of-box strategies to improve organ transplantation. These innovative strategies include the optimized use of organs obtained from deceased patients [e.g., donation after cardiac death (DCD) or brain-dead donors], reducing discards of organs, promoting living donation, and improving the rate of potential organ donation authorization. Thus, the growing demand for organ transplantation leads to the requirement of a more substantial number of HLA testing kits and consumables, which drives the growth of the HLA testing market.

Based on product and services, the human leukocyte antigen (HLA) market is segmented into reagents and consumables, instruments, and software and services. In 2021, the reagents and consumables segment held the largest share of the market. Furthermore, it is expected to register the fastest CAGR of 7.5% during the forecast period.

Based on technology, the human leukocyte antigen (HLA) market is segmented into molecular assay technologies and non-molecular assay technologies. In 2021, the molecular assay technologies segment held a larger share of the market. It is expected to report a higher CAGR of 7.7% during 2022-2028.

Based on end user, the human leukocyte antigen (HLA) market is segmented into independent reference laboratories, hospitals and transplant centers, and others. In 2021, the independent reference laboratories segment held the largest share of the market. On the other hand, the hospitals and transplant centers segment is expected to report the highest CAGR of 7.9% during 2022-2028.

The Global Observatory on Donation and Transplantation (GODT), American Red Cross Organization, US Human Resource and Service Administration (HRSA), Canadian Institute for Health Information, National Registry of Transplants, German Society for Thoracic and Cardiovascular Surgery (GSTCVS), UK Health Security Agency, Spanish National Transplant Organisation (ONT), Japan Organ Transplant Network (JOTN), Saudi Center for Organ Transplantation (SCOT), Business Monitor International (BMI), South African Bone Marrow Registry (SABMR), and World Health Organization (WHO) are among the major secondary sources referred to while preparing the report on the human leukocyte antigen (HLA) market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global human leukocyte antigen (HLA) market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global human leukocyte antigen (HLA) market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Human Leukocyte Antigen (HLA) Testing Market - By Product and Services
    • 1.3.2 Global Human Leukocyte Antigen (HLA) Testing Market - By Technology
    • 1.3.3 Global Human Leukocyte Antigen (HLA) Testing Market - By End User
    • 1.3.4 Global Human Leukocyte Antigen (HLA) Testing Market - By Geography

2. Human Leukocyte Antigen (HLA) Testing Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Human Leukocyte Antigen (HLA) Testing Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East & Africa - PEST Analysis
    • 4.2.5 South & Central America - PEST Analysis
  • 4.3 Expert Opinion

5. Human Leukocyte Antigen (HLA) Testing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Number of Plasma Donation and Organ Transplantation Procedures
    • 5.1.2 Expanding Range of Applications of HLA Testing
  • 5.2 Market Restraints
    • 5.2.1 Errors in Accuracy
  • 5.3 Market Opportunities
    • 5.3.1 Rising Government Funding for Organ Donation
  • 5.4 Future Trends
    • 5.4.1 Technological Advancements in Field of Histocompatibility
  • 5.5 Impact Analysis

6. Global Human Leukocyte Antigen (HLA) Testing Market - Global Analysis

  • 6.1 Global Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis
    • 6.1.1 Global Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis
    • 6.1.2 Global Human Leukocyte Antigen (HLA) Testing Market - Market Potential Analysis, By Region
  • 6.2 Company Analysis
    • 6.2.1 Market Positioning of Key Players in Human Leukocyte Antigen (HLA) Testing Market
    • 6.2.2 Comparative Company Analysis
    • 6.2.3 Growth Strategy Analysis
    • 6.2.4 Performance of Key Players
      • 6.2.4.1 Thermo Fisher Scientific Inc
      • 6.2.4.2 Illumina Corporation

7. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 - by Product and Services

  • 7.1 Overview
  • 7.2 Global Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)
  • 7.3 Reagents and Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents and Consumables: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
  • 7.5 Software and Services
    • 7.5.1 Overview
    • 7.5.2 Software and Services : Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

8. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by Technology

  • 8.1 Overview
  • 8.2 Global Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)
  • 8.3 Molecular Assay Technologies
    • 8.3.1 Overview
    • 8.3.2 Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
    • 8.3.3 PCR-Based Molecular Assays
      • 8.3.3.1 Overview
      • 8.3.3.2 PCR-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
    • 8.3.4 Sequencing-Based Molecular Assays
      • 8.3.4.1 Overview
      • 8.3.4.2 Sequencing-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
    • 8.3.5 Others
      • 8.3.5.1 Overview
      • 8.3.5.2 Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Non-Molecular Assay Technologies
    • 8.4.1 Overview
    • 8.4.2 Non-Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by End User

  • 9.1 Overview
  • 9.2 Global Human Leukocyte Antigen (HLA) Testing Market, By End User 2022 & 2028 (%)
  • 9.3 Independent Reference Laboratories
    • 9.3.1 Overview
    • 9.3.2 Independent Reference Laboratories: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Hospital & Transplant Centers
    • 9.4.1 Overview
    • 9.4.2 Hospital & Transplant Centers: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by Geography

  • 10.1 North America: Human Leukocyte Antigen (HLA) Testing Market
    • 10.1.1 Overview
    • 10.1.2 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
    • 10.1.4 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
      • 10.1.4.1 North America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
    • 10.1.5 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
    • 10.1.6 North America: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
      • 10.1.6.1 US: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.2 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
        • 10.1.6.1.3 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.1.6.1.3.1 US: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.1.6.1.4 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 10.1.6.2 Canada: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.2 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
        • 10.1.6.2.3 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.1.6.2.3.1 Canada: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.1.6.2.4 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 10.1.6.3 Mexico: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Mexico Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.2 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
        • 10.1.6.3.3 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.1.6.3.3.1 Mexico: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.1.6.3.4 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • 10.2 Europe: Human Leukocyte Antigen (HLA) Testing Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
    • 10.2.4 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
      • 10.2.4.1 Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
    • 10.2.5 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
    • 10.2.6 Europe: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
      • 10.2.6.1 Germany: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Germany: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.2 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
        • 10.2.6.1.3 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.2.6.1.3.1 Germany: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.2.6.1.4 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 10.2.6.2 France: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 France: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.2 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
        • 10.2.6.2.3 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.2.6.2.3.1 France: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.2.6.2.4 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 10.2.6.3 UK: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 UK: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.2 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
        • 10.2.6.3.3 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.2.6.3.3.1 UK: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.2.6.3.4 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 10.2.6.4 Italy: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Italy: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.2 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
        • 10.2.6.4.3 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.2.6.4.3.1 Italy: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.2.6.4.4 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 10.2.6.5 Spain: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Spain: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.2 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
        • 10.2.6.5.3 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.2.6.5.3.1 Spain: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.2.6.5.4 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 10.2.6.6 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.2 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.2.6.6.3.1 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • 10.3 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
    • 10.3.4 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
      • 10.3.4.1 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
    • 10.3.5 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
    • 10.3.6 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Country (2022 & 2028) (%)
      • 10.3.6.1 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
        • 10.3.6.1.1 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.2 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
        • 10.3.6.1.3 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
        • 10.3.6.1.3.1 China: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.3.6.1.4 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 10.3.6.2 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.1 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.2 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
        • 10.3.6.2.3 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
        • 10.3.6.2.3.1 Japan: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.3.6.2.4 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 10.3.6.3 India Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
        • 10.3.6.3.1 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.2 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
        • 10.3.6.3.3 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
        • 10.3.6.3.3.1 India: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.3.6.3.4 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 10.3.6.4 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
        • 10.3.6.4.1 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.2 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
        • 10.3.6.4.3 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
        • 10.3.6.4.3.1 South Korea: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.3.6.4.4 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 10.3.6.5 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.1 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.2 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
        • 10.3.6.5.3 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
        • 10.3.6.5.3.1 Australia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.3.6.5.4 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.2 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
        • 10.3.6.6.3.1 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
  • 10.4 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
    • 10.4.4 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
      • 10.4.4.1 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
    • 10.4.5 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
    • 10.4.6 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
      • 10.4.6.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.2 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
        • 10.4.6.1.3 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.4.6.1.3.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.4.6.1.4 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 10.4.6.2 UAE: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.1 UAE: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.2 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
        • 10.4.6.2.3 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.4.6.2.3.1 UAE: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.4.6.2.4 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 10.4.6.3 South Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.1 South Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.2 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
        • 10.4.6.3.3 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.4.6.3.3.1 South Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.4.6.3.4 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 10.4.6.4 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.4.1 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.4.2 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
        • 10.4.6.4.3 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.4.6.4.3.1 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • 10.5 South and Central America Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.3 South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028, By Product and Services (US$ Million)
    • 10.5.4 South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
      • 10.5.4.1 South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
    • 10.5.5 South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
    • 10.5.6 South and Central America: Human Leukocyte Antigen (HLA) Testing Market Share, by Country (2022 & 2028) (%)
      • 10.5.6.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.2 Brazil: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028, By product and service (US$ Million)
        • 10.5.6.1.3 Brazil: Human Leukocyte Antigen (HLA) Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.3.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.5.6.1.4 Brazil: Human Leukocyte Antigen (HLA) Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.2 Argentina: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.1 Argentina: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.2 Argentina: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028, By product and service (US$ Million)
        • 10.5.6.2.3 Argentina: Human Leukocyte Antigen (HLA) Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.3.1 Argentina: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.5.6.2.4 Argentina: Human Leukocyte Antigen (HLA) Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.3 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.1 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.2 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028, By product and service (US$ Million)
        • 10.5.6.3.3 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.3.1 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
        • 10.5.6.3.4 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)

11. Impact of COVID-19 Pandemic on Geographic Regions

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia Pacific: Impact Assessment Of COVID-19 Pandemic
  • 11.4 Middle East & Africa: Impact Assessment Of COVID-19 Pandemic
  • 11.5 South & Central America: Impact Assessment of COVID-19 Pandemic

12. Human Leukocyte Antigen (HLA) Testing Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Human Leukocyte Antigen (HLA) Testing Market (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 THERMO FISHER SCIENTIFIC INC.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 CareDx
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 QIAGEN
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Illumina, Inc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Bio-Rad Laboratories, Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 TBG Diagnostics Limited
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 F. HOFFMANN-LA ROCHE LTD.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Takara Bio Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Luminex Corporation
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Omixon Inc.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 The Sequencing Center
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Protrans
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 HistoGenetics LLC
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 CD Genomics
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Quintara Biosciences
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 CeGaT GmbH
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 CREATIVE BIOLABS, INC.
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 2. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 3. North America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 4. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 5. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 6. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 7. US: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 8. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 9. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 10. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 11. Canada: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 12. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 13. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 14. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 15. Mexico: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 16. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 17. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 18. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 19. Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 20. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 21. Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 22. Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 23. Germany: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 24. Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 25. France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 26. France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 27. France: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 28. France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 29. UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 30. UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 31. UK: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 32. UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 33. Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 34. Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 35. Italy: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 36. Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 37. Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 38. Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 39. Spain: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 40. Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 41. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 42. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 43. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 44. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 45. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
  • Table 46. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
  • Table 47. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 48. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 49. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 50. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 51. China: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 52. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 53. Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
  • Table 54. Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
  • Table 55. Japan: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 56. Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 57. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 58. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 59. India: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 60. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 61. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 62. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 63. South Korea: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 64. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 65. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 66. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 67. Australia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 68. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 69. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 70. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 71. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 72. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 73. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 74. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 75. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 76. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 77. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 78. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 79. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 80. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 81. UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 82. UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 83. UAE: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 84. UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 85. South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 86. South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 87. South Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 88. South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 89. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
  • Table 90. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 91. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 92. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
  • Table 93. South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028, By Product and Services (US$ Million)
  • Table 94. South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 95. South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 96. South and Central America: Human Leukocyte Antigen (HLA) Testing Market for, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 97. Brazil: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028, By Product and Services (US$ Million)
  • Table 98. Brazil: Human Leukocyte Antigen (HLA) Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 99. Brazil: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 100. Brazil: Human Leukocyte Antigen (HLA) Testing Market for, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 101. Argentina: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028, By Product and Services (US$ Million)
  • Table 102. Argentina: Human Leukocyte Antigen (HLA) Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 103. Argentina: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 104. Argentina: Human Leukocyte Antigen (HLA) Testing Market for, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 105. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028, By Product and Services (US$ Million)
  • Table 106. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 107. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
  • Table 108. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market for, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 109. Organic Developments in the Human Leukocyte Antigen (HLA) Testing Market
  • Table 110. Inorganic Developments in the Human Leukocyte Antigen (HLA) Testing Market
  • Table 111. Glossary of Terms, Human Leukocyte Antigen (HLA) Testing Market

List Of Figures

  • Figure 1. Human Leukocyte Antigen (HLA) Testing Market Segmentation
  • Figure 2. Human Leukocyte Antigen (HLA) Testing Market Segmentation, By Region
  • Figure 3. Global Human Leukocyte Antigen (HLA) Testing Market Overview
  • Figure 4. Reagents And Consumables Held Largest Share of Product Segment in Human Leukocyte Antigen (HLA) Testing Market
  • Figure 5. Asia Pacific Region is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Human Leukocyte Antigen (HLA) Testing Market, By Geography (US$ Million)
  • Figure 7. Global Human Leukocyte Antigen (HLA) Testing Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Human Leukocyte Antigen (HLA) Testing Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. South & Central America: PEST Analysis
  • Figure 14. Experts' Opinion
  • Figure 15. HLA Testing Market: Impact Analysis of Drivers and Restraints
  • Figure 16. Global Human Leukocyte Antigen (HLA) Testing Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Human Leukocyte Antigen (HLA) Testing Market- Revenue Forecast and Analysis - 2022 - 2028
  • Figure 18. Global Human Leukocyte Antigen (HLA) Testing Market - Market Potential Analysis, By Region
  • Figure 19. Market Positioning of Key Players in Human Leukocyte Antigen (HLA) Testing Market
  • Figure 20. Global Human Leukocyte Antigen (HLA) Testing Market - Comparative Company Analysis
  • Figure 21. Global Human Leukocyte Antigen (HLA) Testing Market - Growth Strategy Analysis
  • Figure 22. Global Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)
  • Figure 23. Reagents and Consumables: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 24. Instruments: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 25. Software and Services : Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 26. Global Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)
  • Figure 27. Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. PCR-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Sequencing-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Non-Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Global Human Leukocyte Antigen (HLA) Testing Market Share, By End User 2022 & 2028 (%)
  • Figure 33. Independent Reference Laboratories: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Hospital & Transplant Centers: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue Overview, By Key Country - Revenue (2022) (US$ Million)
  • Figure 37. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 38. North America: Human Leukocyte Antigen (HLA) Testing Market, By Country, 2022 & 2028 (%)
  • Figure 39. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 40. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 41. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 42. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue Overview, by Key Country - Revenue (2022) (US$ Million)
  • Figure 43. Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Europe: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
  • Figure 45. Germany: Human Leukocyte Antigen (HLA) Testing Products Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. France: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. UK: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Italy: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Spain: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue Overview, by Key Country - Revenue (2022) (US$ Million)
  • Figure 52. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Country (2022 & 2028) (%)
  • Figure 54. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 55. Japan Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 57. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 58. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 59. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast To 2028 (US$ Million)
  • Figure 60. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 61. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
  • Figure 63. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. UAE: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. South Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. South and Central America Human Leukocyte Antigen (HLA) Testing Market Overview, by Country (2022)
  • Figure 68. South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. South and Central America Human Leukocyte Antigen (HLA) Testing Market Share, by Country (2022 & 2028) (%)
  • Figure 70. Brazil: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. Argentina: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 72. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 73. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 74. Impact of COVID-19 Pandemic on European Country Markets
  • Figure 75. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
  • Figure 76. Impact of COVID-19 Pandemic on Middle East & Africa Country Markets
  • Figure 77. Impact of COVID-19 Pandemic in South & Central America Country Markets
  • Figure 78. Growth Strategies in the Human Leukocyte Antigen (HLA) Testing Market (%)